Treatment of Macular Edema Caused by Leber's Miliary Aneurysms Using Intravitreal Aflibercept and Peripheral Laser Photocoagulation
NCT03908723 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6
Last updated 2019-04-09
Summary
This study evaluates the effectiveness of intravitreal Aflibercept (IVA) injection therapy, combined with peripheral laser photocoagulation, in the treatment of macular edema caused by Leber's miliary aneurysm. We believe that our study makes a significant contribution to the literature because to our knowledge, it is the first to report cases, in which IVA injection therapy was used to treat this condition.
Conditions
- Macular Edema Caused by Leber's Miliary Aneurysms
Interventions
- OTHER
-
Panretinal photocoagulation
Intravitreal Aflibercept with PRP to the peripheral vascular lesions
Sponsors & Collaborators
-
Alexandria University
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 14 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-03-29
- Primary Completion
- 2021-03-29
- Completion
- 2021-05-29
Countries
- Egypt
Study Locations
More Related Trials
-
One Year Results of Switching to Aflibercept for Persistent Diabetic Macular Edema Resistant to Bevacizumab
NCT03974425 ·Status: COMPLETED ·Phase: NA
-
Optic Nerve and Retinal Functions With Bevacizumab
NCT01361828 ·Status: COMPLETED
-
Intravitreal Aflibercept for Treatment of Polypoidal Choroidal Vasculopathy (PCV)
NCT02860858 ·Status: COMPLETED ·Phase: PHASE4
-
Navigated Laser In Branch Retinal Vein Occlusion Study
NCT03651011 ·Status: COMPLETED ·Phase: NA
-
Avastin for Post-photocoagulation Macular Edema
NCT00801866 ·Status: WITHDRAWN ·Phase: PHASE4
-
Effect of Aflibercept (Eylea®) in the Management of Bevacizumab (Avastin®) Resistant Diabetic Macular Edema
NCT02924987 ·Status: UNKNOWN ·Phase: PHASE4
-
Intravitreal Bevacizumab for Inflammatory Neovascular Membranes
NCT00407121 ·Status: WITHDRAWN ·Phase: PHASE3
-
Intravitreal Aflibercept for Therapy of Patients With Pseudoxanthoma Elasticum (PXE)
NCT02537054 ·Status: COMPLETED ·Phase: PHASE2
-
Bevacizumab and Peripheral Retinal Changes on Wide Field Angiography in Diabetic Macular Edema
NCT02096874 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Combined Intravitreal Bevacizumab and Oral Acetazolamide Versus Intravitreal Bevacizumab Alone for the Treatment of Macular Edema Secondary to Retinal Vein Occlusions
NCT05290948 ·Status: UNKNOWN ·Phase: PHASE2
-
Intravitreal Aflibercept for Macular Edema Due to Central Retinal Vein Occlusion
NCT06416241 ·Status: COMPLETED ·Phase: PHASE4
-
Intravitreal Bevacizumab for Nonproliferative Diabetic Retinopathy
NCT04511715 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Bevacizumab and Photodynamic Therapy in Neovascular Age Related Macular Degeneration
NCT00347399 ·Status: TERMINATED ·Phase: PHASE2
-
Intravitreal Bevacizumab vs Laser vs Combination of Bevacizumab and Modified Laser in PDR
NCT04800679 ·Status: UNKNOWN ·Phase: PHASE2
-
Aflibercept and Bevacizumab for Diabetic Maculopathies
NCT06850571 ·Status: RECRUITING ·Phase: PHASE4
-
Laser vs Bevacizumab Injection Alone in Treatment of Diabetic Macular Edema
NCT02229175 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
Pain and Visual Outcome in Intravitreal Bevacizumab Injection
NCT02790775 ·Status: COMPLETED ·Phase: PHASE2
-
Bevacizumab as Adjunctive Treatment to Laser Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
NCT01389505 ·Status: UNKNOWN ·Phase: PHASE2
-
Interval of Disease Inactivity After Complete Polypoidal Regression in PCV Receiving Aflibercept
NCT04707027 ·Status: UNKNOWN ·Phase: NA
-
Intravitreal Bevacizumab vs Photocoagulation for Proliferative Diabetic Retinopathy
NCT00347698 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
Intravitreal Bevacizumab Combined With PDT Versus Bevacizumab to Treat Exudative AMD
NCT00684853 ·Status: UNKNOWN ·Phase: PHASE2
-
Aflibercept Intravitreal Injection for Myopic Choroidal Neovascularization
NCT02033018 ·Status: UNKNOWN ·Phase: PHASE4
-
Evaluation of a Treat and Extend Regimen of Intravitreal Aflibercept for Macular Edema Secondary to CRVO
NCT02800642 ·Status: COMPLETED ·Phase: PHASE4
-
Bevacizumab and Retinal Vascular Occlusions
NCT00347711 ·Status: WITHDRAWN ·Phase: PHASE3
-
Comparison of Bevacizumab and Aflibercept in Treatment of Diabetic Macular Edema
NCT07338097 ·Status: ENROLLING_BY_INVITATION ·Phase: NA